Erik Henke

5.2k total citations · 3 hit papers
48 papers, 3.9k citations indexed

About

Erik Henke is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Erik Henke has authored 48 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Erik Henke's work include Enzyme Catalysis and Immobilization (14 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Angiogenesis and VEGF in Cancer (9 papers). Erik Henke is often cited by papers focused on Enzyme Catalysis and Immobilization (14 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Angiogenesis and VEGF in Cancer (9 papers). Erik Henke collaborates with scholars based in Germany, United States and United Kingdom. Erik Henke's co-authors include Süleyman Ergün, Rajender Nandigama, Uwe T. Bornscheuer, Robert Benezra, Zvi Granot, Elizabeth Comen, Tari A. King, Larry Norton, Ronit Vogt Sionov and Jitka Yehudith Sagiv and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Erik Henke

45 papers receiving 3.9k citations

Hit Papers

Extracellular Matrix in the Tumor... 2011 2026 2016 2021 2020 2015 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Henke Germany 25 1.7k 1.4k 1.3k 582 511 48 3.9k
Per Øyvind Enger Norway 32 1.4k 0.8× 1.2k 0.8× 650 0.5× 369 0.6× 701 1.4× 66 3.6k
Chong-xian Pan United States 31 1.7k 1.0× 1.6k 1.1× 838 0.6× 797 1.4× 504 1.0× 104 4.2k
Karuna Ganesh United States 14 1.4k 0.8× 1.7k 1.2× 828 0.6× 393 0.7× 818 1.6× 37 3.4k
Christine Unger Austria 24 1.6k 0.9× 1.1k 0.8× 450 0.3× 635 1.1× 492 1.0× 34 3.3k
Ahmed Hamaï France 22 1.8k 1.0× 1.1k 0.8× 1.1k 0.8× 312 0.5× 863 1.7× 39 3.6k
Shi‐Cang Yu China 34 2.6k 1.5× 2.1k 1.5× 1.1k 0.8× 557 1.0× 1.6k 3.1× 77 5.4k
Tiziana Triulzi Italy 30 1.7k 1.0× 1.4k 1.0× 713 0.5× 264 0.5× 1.2k 2.3× 61 3.3k
Barbara Muz United States 22 1.3k 0.8× 770 0.5× 484 0.4× 511 0.9× 913 1.8× 58 2.8k
Gennadi V. Glinsky United States 32 2.8k 1.6× 1.0k 0.7× 457 0.3× 329 0.6× 825 1.6× 75 4.1k

Countries citing papers authored by Erik Henke

Since Specialization
Citations

This map shows the geographic impact of Erik Henke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Henke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Henke more than expected).

Fields of papers citing papers by Erik Henke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Henke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Henke. The network helps show where Erik Henke may publish in the future.

Co-authorship network of co-authors of Erik Henke

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Henke. A scholar is included among the top collaborators of Erik Henke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Henke. Erik Henke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinnecker, Jürgen, Mike Friedrich, Rajender Nandigama, et al.. (2024). A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy. Nature Communications. 15(1). 3599–3599. 11 indexed citations
2.
Volz, Julia, Jürgen Pinnecker, Mike Friedrich, et al.. (2023). Image-based modeling of vascular organization to evaluate anti-angiogenic therapy. Biology Direct. 18(1). 10–10. 3 indexed citations
3.
Henke, Erik, Rajender Nandigama, & Süleyman Ergün. (2020). Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy. Frontiers in Molecular Biosciences. 6. 160–160. 783 indexed citations breakdown →
4.
Wörsdörfer, Philipp, et al.. (2019). Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Scientific Reports. 9(1). 15663–15663. 202 indexed citations
5.
Vorlová, Sandra, Franziska Karl, Rajender Nandigama, et al.. (2018). LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy. Oncogene. 37(36). 4921–4940. 69 indexed citations
6.
Henke, Erik. (2018). Centralizers of normal subsystems revisited. Journal of Algebra. 511. 364–387. 3 indexed citations
8.
Henke, Erik, et al.. (2015). Centralizers of normal subgroups and theZ-theorem. Journal of Algebra. 439. 511–514.
9.
Sagiv, Jitka Yehudith, Janna Michaeli, Simaan Assi, et al.. (2015). Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer. Cell Reports. 10(4). 562–573. 622 indexed citations breakdown →
10.
Röhrig, Florian, et al.. (2015). Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models. Scientific Reports. 5(1). 17576–17576. 35 indexed citations
11.
Granot, Zvi, Erik Henke, Elizabeth Comen, et al.. (2011). Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung. Cancer Cell. 20(3). 300–314. 601 indexed citations breakdown →
12.
Vorlová, Sandra, Clare V. LeFave, Francine M. Jodelka, et al.. (2011). Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation. Molecular Cell. 43(6). 927–939. 109 indexed citations
13.
Escorcia, Freddy E., Erik Henke, Michael R. McDevitt, et al.. (2010). Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors. Cancer Research. 70(22). 9277–9286. 70 indexed citations
14.
Shaked, Yuval, Erik Henke, Jeanine M.L. Roodhart, et al.. (2008). Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents. Cancer Cell. 14(3). 263–273. 347 indexed citations
15.
Schmidt, Marlen, et al.. (2004). Directed Evolution of Lipases and Esterases. Methods in enzymology on CD-ROM/Methods in enzymology. 388. 199–207. 17 indexed citations
17.
Henke, Erik, Uwe T. Bornscheuer, Rolf D. Schmid, & Jürgen Pleiss. (2003). A Molecular Mechanism of Enantiorecognition of Tertiary Alcohols by Carboxylesterases. ChemBioChem. 4(6). 485–493. 85 indexed citations
18.
Henke, Erik & Uwe T. Bornscheuer. (2002). Esterases from Bacillus subtilis and B. stearothermophilus share high sequence homology but differ substantially in their properties. Applied Microbiology and Biotechnology. 60(3). 320–326. 35 indexed citations
19.
Henke, Erik, et al.. (2002). Activity of Lipases and Esterases towards Tertiary Alcohols: Insights into Structure���Function Relationships. Angewandte Chemie International Edition. 41(17). 3211–3213. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026